In prostate cancer, ZBTB7A is reported to induce cell proliferation in androgen insensitive prostate cancer cells (PC3) with increased ZBTB7A expression, while acting as a tumor suppressor in androgen sensitive prostate cancer cells (LNCaP) (23, 24). Here, ZBTB7A is linked to prostate carcinoma.